ALB and hepatocellular carcinoma: Multivariate Cox proportional hazards analyses showed that the higher serum anti-PD-1 AAb levels (odds ratio [OR] = 7.8, 95% confidence interval [CI] = 1.5‒39, P = .013), the higher NLR levels (OR = 7.1, 95% CI = 1.6‒31, P = .009), and the lower albumin levels (OR = 14.2, 95% CI = 2.38‒84.9, P = .003) were independent risk factors for the poorer prognosis in patients with HCC who underwent Atezo/Bev therapy as the first-line regimen (Table 5).